Search research articles
Contact Us
Filters
Showing results (41-50 of 94) with videos related to
Page
of 10
Sort By:
The American Journal of Pathology
|
November 8, 2025
Selective Depletion of Gut Gram-Negative Bacteria Attenuates Alcohol Binge-Induced Cardiovascular Dysfunction by Lowering Cardiac Anandamide Levels
Sarah E Cohen, Meagan E Donovan, Davin J Gardner, et al.
Molecules (Basel, Switzerland)
|
July 13, 2024
Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
Biswajit Kundu, Szabolcs Dvorácskó, Abhishek Basu, et al.
Ebiomedicine
|
January 5, 2019
Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis
Rui Benfeitas, Gholamreza Bidkhori, Bani Mukhopadhyay, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 26, 2014
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
Tony Jourdan, Gergő Szanda, Avi Z Rosenberg, et al.
Molecular Pharmacology
|
May 28, 2015
Structural Basis of Species-Dependent Differential Affinity of 6-Alkoxy-5-Aryl-3-Pyridinecarboxamide Cannabinoid-1 Receptor Antagonists
Malliga R Iyer, Resat Cinar, Jie Liu, et al.
Diabetes, Obesity & Metabolism
|
November 7, 2017
Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy
Tony Jourdan, Joshua K Park, Zoltán V Varga, et al.
Diabetes
|
July 19, 2020
Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms
Célia Roger, Chloé Buch, Tania Muller, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 18, 2024
Chronic Alcohol Intake Compromises Lung Immunity by Altering Immunometabolism in Humans and Mouse Models
Lenny Pommerolle, Muhammad Arif, Madeline Behee, et al.
Metabolism: Clinical and Experimental
|
May 14, 2025
Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders
Pinaki Bhattacharjee, Szabolcs Dvorácskó, Océane Pointeau, et al.
Biomed Research International
|
December 19, 2013
Ligand-specific regulation of the endogenous mu-opioid receptor by chronic treatment with mu-opioid peptide agonists
Marianna Murányi, Resat Cinar, Orsolya Kékesi, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 94) with videos related to
Sort By:
Page
of 10
The American Journal of Pathology
|
November 8, 2025
Selective Depletion of Gut Gram-Negative Bacteria Attenuates Alcohol Binge-Induced Cardiovascular Dysfunction by Lowering Cardiac Anandamide Levels
Sarah E Cohen, Meagan E Donovan, Davin J Gardner, et al.
Molecules (Basel, Switzerland)
|
July 13, 2024
Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors
Biswajit Kundu, Szabolcs Dvorácskó, Abhishek Basu, et al.
Ebiomedicine
|
January 5, 2019
Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis
Rui Benfeitas, Gholamreza Bidkhori, Bani Mukhopadhyay, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 26, 2014
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
Tony Jourdan, Gergő Szanda, Avi Z Rosenberg, et al.
Molecular Pharmacology
|
May 28, 2015
Structural Basis of Species-Dependent Differential Affinity of 6-Alkoxy-5-Aryl-3-Pyridinecarboxamide Cannabinoid-1 Receptor Antagonists
Malliga R Iyer, Resat Cinar, Jie Liu, et al.
Diabetes, Obesity & Metabolism
|
November 7, 2017
Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy
Tony Jourdan, Joshua K Park, Zoltán V Varga, et al.
Diabetes
|
July 19, 2020
Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms
Célia Roger, Chloé Buch, Tania Muller, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 18, 2024
Chronic Alcohol Intake Compromises Lung Immunity by Altering Immunometabolism in Humans and Mouse Models
Lenny Pommerolle, Muhammad Arif, Madeline Behee, et al.
Metabolism: Clinical and Experimental
|
May 14, 2025
Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders
Pinaki Bhattacharjee, Szabolcs Dvorácskó, Océane Pointeau, et al.
Biomed Research International
|
December 19, 2013
Ligand-specific regulation of the endogenous mu-opioid receptor by chronic treatment with mu-opioid peptide agonists
Marianna Murányi, Resat Cinar, Orsolya Kékesi, et al.
Page
of 10